登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Nectin-4】

Nectin-4信息

英文名称:Nectin-4
中文名称:细胞黏附分子nectin-4
靶点别称:PRR4,LNIR,Nectin cell adhesion molecule 4,PVRL4,Ig superfamily receptor LNIR,Poliovirus receptor-related protein 4,NECTIN4,Poliovirus Receptor-Related 4,Nectin-4,Nectin 4,EDSS1
上市药物数量:1
临床药物数量:10
最高研发阶段:批准上市

Nectin-4产品列表

货号 物种 产品描述 蛋白结构 纯度 活性
NE4-H52H3
Human
Human Nectin-4 Protein, His Tag (MALS verified)
NE4-H82E7
Human
Biotinylated Human Nectin-4 Protein, His,Avitag™ (MALS verified)
NE4-M52H3
Mouse
Mouse Nectin-4 Protein, His Tag (MALS verified)
CHEK-ATP035
Human
HEK293/Human Nectin-4 Stable Cell Line
MBS-K039
Human
Human Nectin-4-coupled Magnetic Beads
NE4-C5253
Cynomolgus
Cynomolgus Nectin-4 Protein, Fc Tag (MALS verified)
NE4-C52H4
Cynomolgus
Cynomolgus Nectin-4 Protein, His Tag (MALS verified)
NE4-C82E5
Cynomolgus
Biotinylated Cynomolgus Nectin-4 Protein, His,Avitag™ (MALS verified)
NE4-C82F6
Cynomolgus
Biotinylated Cynomolgus Nectin-4 Protein, Fc,Avitag™ (MALS verified)
NE4-H5255
Human
Human Nectin-4 Protein, Fc Tag (MALS verified)
NE4-H82E3
Human
Biotinylated Human Nectin-4 Protein, His,Avitag™ (MALS verified)
NE4-H82Ea
Human
Biotinylated Human Nectin-4 (32-153) Protein, His,Avitag™ (MALS verified)
NE4-H82Ec
Human
Biotinylated Human Nectin-4 (154-243) Protein, His,Avitag™
NE4-H82Ed
Human
Biotinylated Human Nectin-4 (244-349) Protein, His,Avitag™ (MALS verified)
NE4-H82F4
Human
Biotinylated Human Nectin-4 Protein, Fc,Avitag™ (MALS verified)
NE4-HF2H3
Human
FITC-Labeled Human Nectin-4 Protein, His Tag
NE4-M5257
Mouse
Mouse Nectin-4 Protein, Fc Tag (MALS verified)
NE4-M52Ha
Mouse
Mouse Nectin-4 Protein, His Tag, low endotoxin (MALS verified)
NE4-M82E7
Mouse
Biotinylated Mouse Nectin-4 Protein, His,Avitag™ (MALS verified)
NE4-M82F5
Mouse
Biotinylated Mouse Nectin-4 Protein, Fc,Avitag™ (MALS verified)
NE4-R5255
Rat
Rat Nectin-4 Protein, Fc Tag (MALS verified)
ACRO质量管理体系
 
评论(22)
NE4-H52H3|Human Nectin-4 Protein, His Tag (MALS verified)
  1. 156XXXXXXX8
  2. 15人赞
  3. 采购本抗原进行单克隆抗体制备,以及抗体筛选等工作,本抗原经过SDS-PHAGE检测之后,条带单一,无杂蛋白,用于抗体筛选,筛选出的抗体与该抗原具体很好的亲和力
  4. >
  5. 2019-10-11
NE4-M52H3|Mouse Nectin-4 Protein, His Tag (MALS verified)
  1. 156XXXXXXX8
  2. 4人赞
  3. 采购该产品,主要用于抗体分子的种属交叉反应实验,使用该蛋白包被ELISA板子,通过ELISA的方法检测抗体同鼠源Nectin-4的亲和力,在前期的验证阶段,使用已经获批的Enfortumab Vedotin的抗体进行验证,其亲和力EC50值为27ng/ml.
  4. 2021-08-19
NE4-C52H4|Cynomolgus Nectin-4 Protein, His Tag (MALS verified)
  1. 188XXXXXXX5
  2. 4人赞
  3. 采购该蛋白Cynomolgus Nectin-4 Protein, His Tag的应用用途为杂交瘤抗体先导分子,与猴的种属交叉检测检测。与阳参抗体的ELISA亲和结果显示该蛋白具有良好的亲和活性,
  4. 2021-07-17
 

Nectin-4分子别名

NECTIN4,LNIR, PRR4, PVRL4

Nectin-4分子背景

Nectin-4(Nectin cell adhesion molecule 4) is a Nectin and nectin-like family of cell adhesion molecules. It is found in high levels in normal embryonic and fetal tissues, but decreases after adulthood and is limited in distribution in healthy tissues. Nectin-4 is overexpressed in a variety of tumor cells and promotes tumor cell growth and proliferation. Solid tumors with high expression of Nectin-4 include bladder cancer, pancreatic cancer, triple negative breast cancer, non-small cell lung cancer, stomach cancer, esophageal cancer, ovarian cancer and many other cancers. Studies have found that Nectin-4 promotes tumor cell proliferation, differentiation, migration and invasion by activating the PI3K/Akt pathway, and is believed to play an important role in the occurrence and metastasis of cancer. It is based on these research backgrounds that drug research targeting this target has emerged.

Nectin-4上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验
Enfortumab vedotin 维恩妥尤单抗 DLE8519RWM; ASG-22ME; AGS-22M6E; ASG-22M6E; ASG-22CE; AGS-22ME; AGS-22C3; AGS-M6; AGS-22C3E 批准上市 Agensys Inc Padcev United States 尿路上皮癌 Astellas Pharma Us Inc 2019-12-18 肾肿瘤, 实体瘤, 转移性上皮癌, 尿路上皮癌, 胰腺癌, 肿瘤, 去势抵抗性前列腺肿瘤, 膀胱癌, 尿道癌, 原位癌, 输尿管肿瘤, 泌尿系肿瘤, 胰腺导管癌 详情

Nectin-4临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
9MW2821 9MW2821; 9MW-2821; 9-MW2821; 9-MW-2821 临床三期 迈威(上海)生物科技股份有限公司 实体瘤, 尿路上皮癌 详情
BT-8009 BT-8009 临床三期 Bicycle Tx Ltd 卵巢癌, 实体瘤, 三阴性乳腺癌, 尿路上皮癌, 膀胱癌, 非小细胞肺癌 详情
BT-7480 BT-7480 临床二期 Bicycle Therapeutics 实体瘤, 肿瘤 详情
SYS-6002 SYS-6002; SYS6002; CRB-701 临床二期 石药集团巨石生物制药有限公司, 石药集团有限公司 实体瘤 详情
Nectin4/FAP-targeted CAR-T cell therapy (The Sixth Affiliated Hospital of Wenzhou Medical University) 临床一期 温州医科大学, 温州医科大学附属第六医院 实体瘤 详情
ETx-22 ETx-22; LY4101174 临床一期 Emergence Therapeutics AG 卵巢癌, 实体瘤, 盆腔肿瘤, 食道癌, 头颈部鳞状细胞癌, 胰腺癌, 三阴性乳腺癌, 膀胱癌, 前列腺癌, 肺癌, 非小细胞肺癌, 宫颈癌, 转移癌 详情
ADRX-0706 ADRX-0706 临床一期 Adcentrx Therapeutics Inc 实体瘤, 肿瘤 详情
SKB-410 SKB410; SKB-410 临床一期 四川科伦博泰生物医药股份有限公司 实体瘤 详情
BAT-8007 BAT-8007 临床一期 百奥泰生物制药股份有限公司 实体瘤 详情
SHR-A2102 SHR-A2102 临床一期 上海恒瑞医药有限公司 实体瘤 详情

消息提示

请输入您的联系方式,再点击提交!

确定